Global Custom Market Research Reports Provider Company

phone

Repros Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 12 Oct 2018
  • Number of Pages: 32
  • Category: Company Profile
  • Country: United States of America
Summary

Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The companys pipeline product includes enclomiphene and proellex. Its enclomiphene is an orally active proprietary small molecule compound for men of reproductive age with low testosterone due to secondary hypogonadism. The companys proellex is a chemical entity that acts as a selective blocker of the progesterone receptor and is used for the treatment of symptoms associated with uterine fibroids and endometriosis. Repros is headquartered in Houston, Texas, the US.

Repros Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Repros Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Repros Therapeutics Plans to Raise Funds through Public Offering of Shares and Warrants 10
Repros Therapeutics Prices Public Offering of Shares and Warrants for USD3 Million 11
Repros Therapeutics Raises USD2.9 Million in Private Placement of Shares 12
Repros Therapeutics Completes Public Offering Of Shares For US$82 Million 13
Repros Therapeutics Raises USD24 Million in Private Placement Of Shares 15
Repros Therapeutics Completes Private Placement Of Shares For US$11.1 Million 16
Acquisition 17
Allergan to Acquire Repros Therapeutics in Tender Offer 17
Repros Therapeutics Inc - Key Competitors 19
Repros Therapeutics Inc - Key Employees 20
Repros Therapeutics Inc - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Nov 13, 2017: Repros Therapeutics Reports Third Quarter 2017 Financial Results 22
Aug 14, 2017: Repros Therapeutics Reports Second Quarter 2017 Financial Results 24
May 09, 2017: Repros Therapeutics Reports First Quarter 2017 Financial Results 26
Mar 31, 2017: Repros Therapeutics Reports Fourth Quarter and Year End 2016 Financial Results 27
Corporate Communications 28
Apr 10, 2017: Repros Names Larry Dillaha, M.D., its Permanent President and CEO 28
Feb 02, 2017: Repros Announces New CEO 29
Product News 30
12/15/2017: Repros Therapeutics Receives Feedback Following an Oral Explanation with the European Medicines Agency 30
01/26/2018: Repros Announces Negative Opinion From the EMA for Enclomiphene 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables


Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Repros Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Repros Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Repros Therapeutics Plans to Raise Funds through Public Offering of Shares and Warrants 10
Repros Therapeutics Prices Public Offering of Shares and Warrants for USD3 Million 11
Repros Therapeutics Raises USD2.9 Million in Private Placement of Shares 12
Repros Therapeutics Completes Public Offering Of Shares For US$82 Million 13
Repros Therapeutics Raises USD24 Million in Private Placement Of Shares 15
Repros Therapeutics Completes Private Placement Of Shares For US$11.1 Million 16
Allergan to Acquire Repros Therapeutics in Tender Offer 17
Repros Therapeutics Inc, Key Competitors 19
Repros Therapeutics Inc, Key Employees 20

List Of Figures


Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Repros Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

View Report

UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services

View Report

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports